HDR Gateway logo
HDR Gateway logo

Bookmarks

The impact of the use of immunotherapy and risk of type I diabetes mellitus (TIDM) and other immune related adverse events: a population-based observational cohort study

Safe People

Organisation name

CPRD, Utrecht University

Organisation sector

Academic Institute

Safe Projects

Project ID

ODR2122_2709

Lay summary

The impact of the use of immunotherapy and risk of type I diabetes mellitus (TIDM) and other immune related adverse events: a population-based observational cohort study

Latest approval date

22/08/2022

Safe Data

Dataset(s) name